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Herpesviruses encode conserved protein kinases (CHPKs) to stimulate phosphorylation-
sensitive processes during infection. How CHPKs bind to cellular factors and how this
impacts their regulatory functions is poorly understood. Here, we use quantitative proteomics
to determine cellular interaction partners of human herpesvirus (HHV) CHPKs. We find that
CHPKs can target key regulators of transcription and replication. The interaction with Cyclin
A and associated factors is identified as a signature of β-herpesvirus kinases. Cyclin A is
recruited via RXL motifs that overlap with nuclear localization signals (NLS) in the non-
catalytic N termini. This architecture is conserved in HHV6, HHV7 and rodent cytomega-
loviruses. Cyclin A binding competes with NLS function, enabling dynamic changes in CHPK
localization and substrate phosphorylation. The cytomegalovirus kinase M97 sequesters
Cyclin A in the cytosol, which is essential for viral inhibition of cellular replication. Our data
highlight a fine-tuned and physiologically important interplay between a cellular cyclin and
viral kinases.
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Herpesviruses are a wide-spread family of large, double-stranded DNA viruses replicating within the nuclei oftheir host cells. Generally, herpesviruses are highly
adapted to their hosts and persist in a latent mode of infection
unless immunodeficiency provokes viral reactivation and dis-
ease1. They have diversified into three subfamilies: neurotropic α-
herpesviruses, broadly infective β-herpesviruses, and lympho-
tropic γ-herpesviruses. Despite their widely different pathogenic
properties and clinical manifestations, all herpesviruses share a
common set of conserved core genes, mostly encoding essential
structural components and replication factors2. Among the few
core genes with regulatory function are the conserved herpesvirus
protein kinases (CHPKs)3, which are medically important both as
drug targets4 and as prodrug activating enzymes5.
CHPKs belong to the group of viral serine/threonine kinases6.
Although possessing a considerable sequence divergence, CHPKs
have a number of common characteristics including autopho-
sphorylation, nuclear localization, incorporation into the tegument
layer of virus particles, and phosphorylation of other tegument
proteins6. CHPKs target regulators of the DNA damage check-
point7,8, phosphorylate the translational elongation factor EF-1δ9,
and counteract the IRF3-dependent type I interferon response10.
CHPKs were reported to preferentially target cellular cyclin-
dependent kinase (CDK) phosphorylation sites11,12. In particular,
the kinases of human β- and γ-herpesviruses show significant
structural and functional homology to CDKs13–16. This has led to
their designation as viral CDK-like kinases (v-CDKs)13. V-CDKs
lack amino acids that are known to be essential for interaction of
cellular CDKs with cyclins, CDK inhibitors (CKIs) and CDK acti-
vating kinases (CAKs). Accordingly, v-CDKs are considered
immune to cellular control mechanisms17, despite the fact that the
UL97 kinase of human cytomegalovirus (human herpesvirus 5,
HHV5) can physically interact with various cyclins18. V-CDKs
mimic CDK1 and 2 in phosphorylating Lamin A/C13,14,
retinoblastoma-associated tumor suppressor RB1 (refs. 13,17,19),
and deoxynucleoside triphosphate (dNTP) hydrolase SAMHD1
(refs. 20,21). Collectively, the CDK-like activities of CHPKs facilitate
the nuclear egress of virus capsids22 and secure the supply of dNTPs
and cellular replication factors for viral DNA replication20,23.
Significant knowledge has accumulated over the recent years
about CHPK functions. It is known that CHPKs can recruit
cellular proteins as substrates via conserved docking motifs19,24.
Further, CHPKs can be regulated by their interaction partners
and even exert kinase independent functions25,26. However, a
systematic analysis of CHPK protein–protein interactions is
lacking and data linking interactions to functions of the kinase are
scarce. To broaden our understanding of CHPKs, we used an
affinity purification–massspectrometry (AP–MS) approach and
identified shared and differential interaction partners of CHPKs
from all herpesvirus subfamilies. We found that Cyclin A–CDK
complexes build a common set of interactors for β-herpesvirus v-
CDKs. Taking mouse cytomegalovirus (MCMV, murid herpes-
virus 1 (MuHV-1)) as a model system, we show that during
infection the stoichiometric formation of cytoplasmic v-CDK and
Cyclin A assemblies causes a global shift in substrate phosphor-
ylation and the viral shutoff of host DNA synthesis. Collectively,
our data demonstrates that herpesvirus kinases have evolved as
protein-interaction hubs that can recruit a rich repertoire of
cellular proteins. The functional versatility of β-herpesvirus v-
CDKs is underpinned by their ability to cross-talk with a cellular
cyclin via direct, non-catalytic interaction.
Results
CHPKs target key regulators of transcription and replication.
Systems-level approaches have provided important insights into
the molecular functions of CHPKs. For example, yeast 2-hybrid
screens revealed several binary binding partners of CHPKs27,28
and phosphoproteome profiling was successfully used to assess
CHPK substrate specificity7,12,29,30. However, comprehensive and
comparative information about CHPK interaction partners at the
proteome level is lacking.
To identify CHPK interaction partners, we transfected SILAC
(stable isotope labeling of amino acids in cell culture) heavy and
light labeled HEK-293T cells with HA-tagged CHPKs of seven
different human herpesviruses (HHVs) or vector controls. We
performed these experiments in triplicates, including label-swaps
(Fig. 1a), and subjected the samples to HA affinity purification
(HA-AP) and shotgun proteomics. We specifically detected the
baits in extracts of transfected cells and in eluates of HA-APs
(Supplementary Fig. 1a, b). The baits were among the most
abundant proteins in the eluates (Supplementary Fig. 1c),
consistent with good enrichment. We observed an overall good
reproducibility of SILAC fold-changes for the individual replicates
(Supplementary Fig. 2a). To discriminate candidate interactors
from background binders, they were required to fall below a
p-value of 0.05 and meet a SILAC fold-change cut-off at 1% false
discovery rate (FDR). (Fig. 1b, Supplementary Fig. 2b, c). We
quantified about 1500–2000 proteins in individual samples
(Supplementary Fig. 1d) and classified 135 proteins as candidate
interaction partners to at least one kinase (Supplementary Data 1).
This list includes several previously found CHPK interactors and
substrates, such as SAMHD1 (ref. 20), RBL2 (ref. 31), PPP2CA,
PUM1, PRDX1 (ref. 7), and NUMA1, TUBA1B, MAP7D1 (ref. 30).
We next aimed to determine interaction partners that were
common to all kinases, class-specific (i.e., restricted to either
kinases of α, β, or γ-classes) or unique to individual kinases.
Therefore, we clustered the SILAC fold-changes of candidate
interactors across all tested kinases (Fig. 1c). We found the
chaperonin containing TCP1 and the kinase maturation complex
(CDC37, HSP90) to co-purify with all kinases analyzed. This
confirms the previous observation that CHPKs interact with the
same set of cellular proteins that assist in folding and maturation
of cellular kinases32,33.
Proteins that co-purified with BGLF4 (HHV4, Epstein–Barr-
virus), but were not significantly enriched with other kinases,
include factors involved in DNA replication (HERC2, E4F1,
PCNA, SSBP1) and chromatin silencing (SMCHD1, CABIN1,
HIRA, BEND3). Proteins that co-purified with pUL97 (HHV5)
but not other kinases were functionally related to regulation
of transcription (PHC2, RING1, CBX4, TRIM28, ZNF136,
ZNF791). To validate our approach, we performed an
additional SILAC AP–MS experiment directly comparing
proteins enriched to BGLF4 and pUL97 (Supplementary
Fig. 3a). Again, we found selective enrichment of the specific
sets of host interactors described above to either BGLF4 or
pUL97 (Supplementary Fig. 3b, Supplementary Data 2). By
performing co-immunoprecipitation (co-IPs) experiments, we
were able to validate the transcriptional regulators SPOP,
CCAR2, BMI1, and TRIM28 as specific interactors of pUL97
(Supplementary Fig. 3c–f).
Importantly, we found that all human β-herpesvirus kinases
co-purify with S/G2 phase-specific cyclins (Cyclin A, gene
symbol: CCNA2, Cyclin B, gene symbol: CCNB1), CDKs
(CDK1, CDK2), and associated proteins (SKP1, SKP2). While
enrichment of Cyclin A–CDK2 was reproducibly strong, Cyclin
B–CDK1 did not enrich with pUL97 in our transfection
experiment (Fig. 1d). We were able to validate the interaction
with Cyclin A–CDK2 by reverse co-IPs. Also, we observed this
type of interaction for the homologous M97 kinase of MuHV-1,
better known as MCMV (Fig. 1e). Collectively our interactome
of human CHPKs provides a rich resource and suggests
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that these kinases are crucially involved in the regulation
of transcription, epigenetic remodeling, and cell cycle control.
Cyclin A–CDK2 complexes build a common subset of
interactors for β-herpesvirus kinases, suggesting important
functional implications.
β-herpesvirus kinases bind cyclin–CDKs via NLS-RXL mod-
ules. β-herpesvirus kinases lack most of the residues of CDKs that
directly interact with cyclins, including a conserved PSTAIRE
helix17. Instead, we found RXL/Cy motifs in the N-terminal, non-
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Ubiquitin E3 ligase 
p: 5.1E–11
Cyclin A:Cdk2-associated events 
at S phase entry
p: 1.2E–10
HHV5-UL97 V R R A L F T 171 – 177
HHV6-U69 V K R K L F A 35 – 41
HHV7-U69 V K R K L F G 33 – 39
MuHV1-M97 V K R R L V F 43 – 49
MuHV2-R97 V R R R L V F 55 – 61
MuHV8-E97 V K R R L V F 37 – 43
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are typically used for substrate and inhibitor recruitment to
cyclin–CDKs34. Importantly, the positions of the RXL-type
sequences within the largely divergent N termini are well con-
served (Supplementary Fig. 4). These putative Cyclin A binding
elements in β-herpesvirus kinases of the roseolovirus (HHV6,
HHV7) and muromegalovirus (MuHV1, MuHV2, MuHV8)
genera are in close proximity to clusters of positively charged
residues (Supplementary Fig. 4), which are predicted, and in the
case of HHV6 validated, classical bipartite nuclear localization
signals (NLS)35. In fact, the C-terminal part of the NLS sequences
directly overlaps with the N-terminal part of the RXL motifs
(Fig. 2a). Thus, when we set out to test the contribution of RXL
motifs in U69 and M97 to Cyclin A binding, we had to consider
the possibility that RXL mutations may negatively affect NLS
function. We therefore designed two mutant versions of each
kinase: one disrupting the core of the RXL motif (RXL− > AXA)
and one changing only the hydrophobic part (LF− > AA, LXF−
> AXA), leaving the basic residues of the NLS intact (Fig. 2a).
Both mutations abolished binding of M97 and U69 kinases to
Cyclin A (Fig. 2b). Thus, RXL sequence motifs found in β-
herpesvirus kinases act as Cyclin A docking sites. RXL mutation
not only prevents Cyclin A binding but also interaction with
other cyclin-associated factors found in the interactome analysis
(Fig. 1c), as exemplarily shown for HHV6-U69 (Supplementary
Fig. 5). This indicates that those factors are not direct v-CDK
interactors but instead co-recruited with Cyclin A. Thus, the RXL
motif triggers the formation of higher-order v-CDK–cyclin–CDK
complexes.
We then assessed the consequences of RXL mutations for NLS
function. To this end, we cloned 32–37 amino acid segments
encompassing the overlapping NLS and RXL elements of M97
and U69 kinases into an NLS reporter construct36 (Fig. 2c).
Integration of wild-type (WT) NLS-RXL regions into the
chimeric reporter induced nuclear accumulation of the otherwise
cytoplasmic GFP signal (Fig. 2d, e), indicative of a functional
NLS. RXL to AXA mutations weakened this activity in HHV6-
U69 and even disrupted it in M97. By contrast, the NLS function
remains intact when only the hydrophobic residues of the RXL/
Cy motifs are mutated (Fig. 2d, e). These results demonstrate that
cyclin binding and NLS sequences are integrated into a composite
motif that can be functionally separated by mutations.
M97 assembles cyclin–CDK complexes in infected cells. We
then aimed to analyze the NLS-RXL module in a representative
infection system and chose MCMV for ease of manipulation. We
first assessed the time-resolved protein interactome of M97 using
SILAC and AP–MS (Supplementary Fig. 6a, Supplementary
Data 3). Early during infection (12 h), the M97 interactome
consisted almost exclusively of cyclins, CDKs, and associated
proteins (Supplementary Fig. 4b). In the late phase (36 h), addi-
tional viral and cellular factors co-purified with M97 (Supple-
mentary Fig. 4d), including M50–M53, the nuclear egress
complex of MCMV37, and Lin54, the DNA-binding subunit of
the cell cycle regulatory MuvB complex38, which is known to be
regulated by pUL97 (ref. 39). Taken together, this indicates that
M97 functions in cell cycle regulation, viral egress, and control of
gene expression.
In consistency with the data from transfected cells, M97
interacted with Cyclin A/B–CDK complexes throughout infection
(Fig. 3a, Supplementary Fig. 6b,d). In particular, Cyclin A–CDK2
was present in similar molar amounts as M97 itself in HA-M97
MS samples (Supplementary Fig. 6c, e), suggesting a strong and
stoichiometric interaction in infected cells. Mutation of the RXL/
Cy motif (Supplementary Fig. 5) disrupted the interaction of
Cyclin A with M97 (Fig. 3c, d). However, these mutations did not
influence Cyclin A protein levels (Fig. 3b) or Cyclin A-associated
kinase activity (Fig. 3f). Moreover, RXL/Cy mutations, in contrast
to the “kinase dead” K290Q mutation23, did not compromise
M97 levels and activity (Fig. 3b, e). Thus, M97–Cyclin A binding
has no influence on abundance and enzymatic activity of the
involved interaction partners. This is consistent with the view that
β-herpesviral CHPKs are cyclin-independent kinases17.
Cyclin binding controls subcellular localization of M97. In
respect of the overlapping NLS and RXL/Cy motifs within M97,
we next tested whether Cyclin A binding alters the subcellular
localization of M97. To address this, we chose a system where
Cyclin A levels are dynamically changing. In quiescent cells,
Cyclin A is absent at very early time points of infection (Fig. 3b)
and induced between 6 and 24 h by MCMV (Fig. 3b). Using
immunofluorescence microscopy, we observed that M97-WT is
nuclear at 8 h post infection (Fig. 4a), when Cyclin A is still low,
but redistributes to a predominantly cytoplasmic localization
pattern at 24 and 48 h post infection (Fig. 4a, middle left column),
when Cyclin A levels are high. Thus, the appearance of M97 in
the cytosol correlates with increased Cyclin A expression.
Then we tested the contribution of the RXL/NLS module to the
time dependent change in M97 localization. When the NLS
function was disrupted by R45A/L47A mutation, M97 was
confined to the cytoplasm throughout infection (Fig. 4a, b, middle
right column). By contrast, when the NLS part of the NLS-RXL
module was left intact and only Cyclin binding was prevented
(L47A/F49A), M97 showed a constitutively nuclear localization
pattern (Fig. 4a, b, right column). Thus, Cyclin A binding is
responsible for the late relocalization of M97. This provides
evidence for a scenario, where Cyclin A masks the NLS and
thereby effectively interferes with nuclear entry of M97.
Fig. 1 CHPKs target key regulators of cellular replication and transcription. a Experimental setup. SILAC heavy and light labeled HEK-293T cells were
transfected with constructs encoding HA-tagged versions of human herpesviral kinases or control vectors in triplicates (n= 3). Samples were subjected to
anti-HA affinity purification followed by mass-spectrometry. b Candidate selection. Candidate interaction partners were distinguished from background
binders based on a combination of the t-test p-value of three replicates and the mean of the SILAC ratios. P-value cut-off at 0.05 and fold-change cut-off at
FDR= 1%. A volcano plot for the HHV6-U69 kinase is exemplarily shown. c Cross-comparison of kinase interaction partners. All candidate interaction
partners were compared for co-enrichment across the indicated kinases of α-, β-, and γ-HHVs. Enrichment profiles were clustered and selected sets of
clusters were subjected to GO enrichment (inlet and brackets). d Cyclin–CDK complexes co-purify with β-herpesviral kinases. Depicted are the SILAC
ratios of individual replicates (n= 3) for prey proteins CDK1, CCNB1, CCNA2, and CDK2 across AP–MS samples of the indicated kinases. e Validation of
Cyclin A–CDK binding to β-herpesviral kinases. Whole cell extracts from transfected 293T cells were subjected to Cyclin A co-IP and analyzed by
immunoblotting for the presence of Cyclin A, CDK2, and HA-tagged kinases. The immunoblots are representative of three independent experiments with
similar results. f Alignment of putative Cyclin A binding sites in human and rodent β-herpesvirus kinases. Basic residues are highlighted in blue, bulky
hydrophobic residues in pink. g Schematic of human herpesviral kinases. Shown are the location of the conserved catalytic domains and the relative
positions of RXL/Cy motifs (pink) and predicted or experimentally validated nuclear localization signals (NLS) (gray) within the less-conserved N-terminal
parts of the proteins.
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Next, we studied how the dynamic and Cyclin A-dependent
relocalization of M97 impacts protein phosphorylation. There-
fore, we compared cells that were either infected with RXL
deficient MCMV-M97L47A/F49A or NLS-RXL deficient MCMV-
M97R45A/L47A. The two mutant viruses reflect the early nuclear or
late cytosolic localization of M97 during MCMV-WT infections.
We globally assessed substrate phosphorylation by performing a
proteomic analysis of phosphopeptides and whole cell lysates of
SILAC-labeled cells at 24 h post infection (Supplementary Fig. 8a,
Supplementary Data 4).
First, we corrected phosphosite ratios for protein level
changes (Supplementary Fig. 8b, c). Next, we categorized
proteins and corresponding phosphosites based on their GO
annotation as nuclear, cytoplasmic or unclear (“no category”)
(Supplementary Fig. 8d). Then, we specifically analyzed pho-
sphosites that match known v-CDK target motifs12,
such as pSP, pSXXK, LXpSP (p denotes the phosphorylated
residue). When cells were infected with M97R45A/L47A mutant,
pS/TP and pSXXK sites residing in the cytosol were signifi-
cantly stronger phosphorylated than nuclear sites (Fig. 4c). By
contrast, when cells were infected with the M97L47A/F49A
mutant, the same set of sites were stronger phosphorylated
when they belonged to nuclear proteins. The most pronounced
differences in the target spectrum were observed when
phospho-serines followed by prolines were positioned between
hydrophobic amino acids and lysines (Supplementary Fig. 8e).
Collectively, these data argue that Cyclin A binding enables
switch-like changes in the substrate spectrum and subcellular
distribution of M97.
M97 inhibits host DNA synthesis by Cyclin A sequestration.
The binding of M97 to Cyclin A may have functional con-
sequences not only for M97 but also for Cyclin A. Cyclin A is
essential for cellular DNA replication and cell cycle progression
from S phase to mitosis40. Importantly, Cyclin A function
depends on its nuclear localization41,42. Therefore, we analyzed
whether M97 binding impacts the subcellular distribution of
Cyclin A. We found Cyclin A, and to a lesser extent CDK2, to be
depleted from the nucleus in MCMV-WT-infected cells (Fig. 5a).
This effect was Cyclin A specific as Cyclin E was evenly dis-
tributed between nuclear and cytoplasmic fractions. Mutation of
the M97 translation start site prevented the cytoplasmic enrich-
ment of Cyclin A. Mutations of the RXL/Cy motif in M97 even
led to a predominant nuclear localization of Cyclin A. Thus,
Cyclin A is sequestered within the cytosol dependent on its
binding to M97.
This observation prompted us to investigate whether the














































































































































































n = 781 n = 1351 n = 1650 n = 451 n = 853 n = 729n = 1261
Fig. 2 NLS and RXL/Cy motifs overlap in U69 and M97 kinases.
a Sequence alignment of overlapping NLS-RXL elements in M97 and U69
kinases. Stretches of basic residues characteristic for nuclear localization
signals (NLS) are highlighted in blue, conserved leucine and phenylalanine
residues participating only in the RXL/Cy motif in pink. A mutation strategy
was designed to separate NLS function from cyclin binding. RXL-AXA
mutations affect both RXL and NLS sequences, LXF-AXA and LF-AA
mutations only the RXL/Cy motif. b HEK-293T cells were transfected with
HA-tagged wild-type (WT) or mutant forms of U69 and M97 kinases.
Cyclin A co-IP was carried out at 2 days post transfection and analyzed by
immunoblotting for the presence of viral kinases and Cyclin A. The
immunoblots are representative of three independent experiments with
similar results. c Sequence fragments encompassing the NLS-RXL region of
U69/M97 mutant and wild-type kinases were cloned between and in-frame
with the green fluorescent protein (GFP) and β-galactosidase genes in
pHM830. d, e 293T cells were transfected with the M97/U69-NLS
reporter constructs, as indicated. The subcellular localization of GFP was
analyzed at 24 h post transfection using confocal live-cell imaging
microscopy. Nuclei were counterstained with Hoechst-33342. Scale bars:
10 μm. e The indicated number of cells were categorized based on the
subcellular localization of the GFP reporter relative to the Hoechst stain.
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progression. Therefore, we measured the DNA content of
quiescent fibroblasts infected with WT and M97 mutant
viruses by flow cytometry (Fig. 5b, c, Supplementary Fig. 9).
We found a ganciclovir-sensitive increase of viral DNA in
MCMV-WT-infected cells, consistent with previous reports43.
By contrast, M97 mutant viruses caused a rapid and
ganciclovir-resistant accumulation of cells with a G2/M DNA
content. The latter phenotype was reversed by stable and
efficient knockdown of Cyclin A (Supplementary Fig. 10).
These observations demonstrate that loss of M97–Cyclin A
interaction causes S phase entry and cell cycle progression to
G2/M phase.
We aimed to confirm the crucial role of M97–Cyclin A
interaction for inhibition of cellular DNA synthesis by an
orthogonal approach. We chose to combine EdU pulse labeling
and fluorescence microscopy to spatially discriminate sites of
active viral or cellular DNA synthesis. In MCMV-WT-infected
cells, DNA synthesis is confined to nuclear replication compart-
ments that stain positive for the viral single-stranded DNA-
binding protein M57 (Fig. 5d, e). By contrast, cells infected with
M97-RXL/Cy mutants incorporated EdU in foci distributed over
the whole nucleus, indicating that the restriction of cellular DNA
replication was lost. Thus, M97–Cyclin A complex formation
serves as a mechanism to shut off competing host DNA synthesis
during productive infection.
Very similar results were obtained in primary, non-immortalized
mouse embryonic fibroblasts (MEF), the only difference being that
here the RXL/Cy mutation leads to a cellular DNA content that
exceeds the normal 4n DNA content of diploid G2/M cells
(Supplementary Fig. 11). This indicates that the M97 mutant virus











































































































































































































































































































Fig. 3 Formation of M97–cyclin–CDK assemblies during infection. a A time-resolved interactome of M97 during MCMV infection (Supplementary
Fig. 6). Enrichment ratios for proteins co-purifying with HA-M97 at 12 or 36 h post infection in a scatterplot. The cut-off at SILAC fold-change 1.5 is
indicated by a red dotted line. The mean of n= 3 replicates is depicted. b–f Serum-starved 3T3 fibroblasts were infected with the indicated MCMV-
HA-M97 variants. b The expression of Cyclin A and of selected immediate-early, early and late MCMV gene products was monitored by immunoblot
analysis. Affinity purification of the indicated HA-M97 variants by anti-HA-coupled paramagnetic microbeads (c) or reverse co-IP (d) confirms RXL/
Cy-dependent interaction with Cyclin A–CDK2. Assays for M97 (e) and Cyclin A (f) enzymatic activity. Lysates from MCMV-infected 3T3 fibroblasts
were subjected to anti-HA-IP (e) or Cyclin A-IP (f) and used as input material for γ-P32-ATP kinase assay. Recombinant Histone H1 was used as RXL/
Cy-independent Cyclin A substrate and autophosphorylation of M97 was measured for the M97 kinase assay. Incorporation of γ-P32-ATP was
visualized by autoradiography. The immunoblots (b–f) and autoradiograph (f) are representative of three independent experiments with similar
results.
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Although M97 is not essential for MCMV in vitro, its deletion
negatively affects virus growth44. When we tested our set of M97
mutants on MEFs, a virus growth curve analysis revealed that the
NLS-RXL module has a larger impact on virus replication than the
kinase activity itself (Fig. 5f). This underlines the importance of
nonenzymatic protein–protein interactions for the proper function
of conserved β-herpesvirus kinases during the virus life cycle.
Discussion
Here, we present the first comparative analysis of CHPK inter-
actomes. Our analysis led to the identification of host–protein
interaction signatures that are common, class-specific or unique
to CHPKs (Fig. 1c). The interaction of β-herpesvirus-CHPKs with
Cyclin A orchestrates higher-order complex formation of cell
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regulatory and has functional consequences for both, the CHPK
and Cyclin A. For MCMV, it results in the dynamic relocalization
of the viral kinase (Fig. 4a) and consequently an altered substrate
spectrum (Fig. 4b). Further, the interaction leads to cytosolic
sequestration of Cyclin A, which is essential for viral arrest of
DNA replication (Fig. 5).
V-CDKs are a subset of CHPKs that share key aspects of host
CDK-function and the ability to complement for CDK activity in
yeast cells13,14,17. V-CDKs have lost sequence features enabling
control by cellular factors, such as CAK, CKI, and cyclins17.
Instead, we show that some v-CDKs acquired RXL motifs (Fig. 1),
which are typically used by cellular CDK substrates and inhibitors
for recognition by cyclins34,45. These motifs enable a regulatory
cross-talk of Cyclin A and v-CDKs, which is characterized by cell
cycle dependent regulation of the viral kinase on the one hand
(Fig. 4) and neutralization of Cyclin A in stoichiometric protein
assemblies on the other hand (Fig. 5, Supplementary Figs. 6 and
10, 11). The latter effect of v-CDK–Cyclin A interaction is
reminiscent of CKI function. Thus, we propose that β-
herpesviruses integrate the antipodal activities of CDKs and
CKIs on one gene product. This combination allows a β-
herpesvirus kinase like M97 to activate S/G2 metabolism23 while
inhibiting cellular DNA synthesis (Fig. 5).
An exception among human β-herpesviruses is HCMV, which
has evolved a different gene product for neutralization of Cyclin
A. HCMV produces the small protein pUL21a, which targets
Cyclin A for proteasomal degradation46,47. Therefore, it seems
that HCMV has shifted its Cyclin A-antagonistic, CKI function
from its kinase to pUL21a. In that context it is interesting that the
RXL motif in HCMV-pUL97 does not overlap with an NLS48,
suggesting an alternative function of pUL97–Cyclin A interaction
(Fig. 1).
Short linear motifs (SLiMs) can be rapidly acquired by viruses
and other pathogens to target host proteins49,50. Here, we found
that within HHV6, HHV7, and rodent CMV kinases two such
SLiMs are fused into one regulatory sequence element (Fig. 2).
The physical overlap of RXL/Cy and NLS motifs is facilitated by
their sequence composition as both contain contiguous stretches
of basic amino acids. NLS motifs function as docking sites for
nuclear import factors, mainly importin-α51. Accordingly, a
docking competition mechanism makes binding to Cyclin A and
nuclear localization of M97 mutually exclusive, enabling switch-
like changes in viral kinase function (Fig. 6a). This puts β-
herpesvirus kinases in a row with a number of cellular and viral
proteins known to control nucleo-cytoplasmic localization via
intermolecular NLS-masking, with NF-κB as the best understood
example52.
Remarkably, composite NLS-RXL/Cy elements are apparent in a
number of key regulatory proteins of the host cell cycle. Although
independently described, NLS and RXL/Cy motifs are overlapping
in RB1 (refs. 53,54), CDKN1A (also known as p21)45,55, E2F1
(refs. 56,57), and CDT1 (refs. 58,59) (Fig. 6b). This feature is highly
conserved in vertebrate orthologues (Supplementary Fig. 12). For
these cellular factors, it could be important to consider a docking
competition between Cyclin A and importins, a possibility which is
so far unexplored. Specifically, cyclin binding may be essential for
the cell cycle dependent localization of these proteins57,60,61. In
other cases, such as CDC6, RXL motifs are adjacent to but not
overlapping with NLS. There, Cyclin A recruits CDKs to neutralize
the NLS by phosphorylation62.
In addition to the functionally important interaction of β-
herpesvirus kinases with Cyclin/CDKs, our unbiased proteomic
survey indicates that CHPKs interact with many more cellular
proteins (Fig. 1c, Supplementary Data 1). Consistent with pre-
vious reports, many CHPK interaction partners are functionally
related to DNA repair7 and cell cycle control13. Remarkably, we
found that CHPKs also interact with a variety of prominent
transcriptional repressor complexes. For example, pUL97 inter-
acts with TRIM28-ZNF complexes (Fig. 1c, Supplementary
Fig. 3e), known to silence CMV gene expression in stem cells
depending on the phosphorylation status of TRIM28 (ref. 63). In
addition, pUL97 co-purifies with PHC2, RING1, CBX4, and
BMI1 (Fig. 1c, Supplementary Fig. 3f), all members of the poly-
comb repressive complex 1, which was recently linked to control
of HCMV replication64. Likewise, we found BGLF4 to interact
with core subunits of the HIRA histone chaperone complex
(HIRA, CABIN1, and UBN2). This complex restricts lytic infec-
tion by depositing histone H3.3 on incoming herpesvirus gen-
omes65. Collectively, these data indicate that CHPKs can target
host-derived master regulators of viral transcription, governing
the decision between lytic and latent infection programs. This
could allow tegument-delivered CHPKs to actively influence the
outcome of herpesvirus infections.
Our interactome analysis indicates that CHPKs target master
regulators involved in host replication, DNA repair, and tran-
scription. It is important to note that this type of experiment
cannot resolve protein interactions that depend on the environ-
ment of an infected cell. For example, CHPKs may be differen-
tially abundant, differently modified, differently folded, or
differently localized in transfected compared to infected cells. It is
thus critical to interpret our findings in the broader context of
kinase-associated functions that dynamically change during
infection. For instance, phosphorylation of the nuclear protein
SAMHD1 could be maintained by the M97 kinase early during
infection23 when M97 localizes nuclear (Fig. 4a). During later
stages of infection, the nuclear lamina is locally disassembled and
egress of viral capsids to the cytoplasm occurs. The shift from
nuclear replication to cytosolic assembly is accompanied by the
concurrent relocalization of the viral kinase. Thus, Cyclin A
interaction helps the kinase to exert infection stage-specific
functions.
Methods
Cells. HEK-293T cells and NIH-3T3 fibroblasts were cultivated in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% fetal (293T) or newborn
(3T3) bovine serum, 2 mM L-alanyl-L-glutamine, 100 UmL−1 penicillin, and
Fig. 4 The RXL-NLS module controls M97 localization and substrate phosphorylation. a Serum-starved 3T3 fibroblasts were infected with the indicated
MCMV-HA-M97 variants or left uninfected. At 8, 24, and 48 h post infection, cells were examined by confocal immunofluorescence microscopy for
subcellular localization of HA-M97 (green). Nuclei were counterstained with DAPI. Scale bars: 10 μm. Representative images are shown. b The indicated
number of cells were categorized based on the subcellular localization of HA-M97 relative to the DAPI stain. c SILAC-labeled 3T3 cells were serum starved
and infected with NLS-RXL/Cy-deficient M97R45A/L47A or RXL/Cy-deficient M97L47A/F49A viruses (Supplementary Fig. 6). At 24 h post infection cells
were harvested and subjected to a phosphoproteomic workflow. Boxplots for phosphosites that belong to proteins with nuclear, cytoplasmic, or
uncategorized subcellular GO annotation are depicted with their SILAC log2 fold-change between M97R45A/L47A and M97L47A/F49A infection. pSP, pSXXK,
LXpSP, or all other sites were assessed individually. Center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; outliers
(data points outside the whiskers) were removed for visibility. P-values are based on an one-sided Wilcoxon rank-sum test comparing nuclear and
cytosolic subsets. Data represent the mean of n= 2 replicates.
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100 µgmL−1 streptomycin. Where indicated, cells were synchronized in G0/G1
phase by 48 h growth factor deprivation (0.05% serum). In preparation for pro-
teomic analysis, cells were SILAC-labeled for at least five passages using lysine and
arginine-deprived DMEM, supplemented with 10% dialyzed serum (cut-off: 10
kDa), 200 mg/L L-proline (only cells destined for phosphoproteome analysis),
heavy (L-[13C6,15N2]-lysine (Lys8), L-[13C6,15N4]-arginine (Arg10)), medium
(L-[2H4]-lysine (Lys4), L-[13C6]-arginine (Arg6)) or light (natural lysine (Lys0) and
arginine (Arg0)) amino acids. Labeling efficiency and arginine–proline conversion
was checked using LC–MS/MS.
Viruses. Viruses were derived from the m129-repaired MCMV strain Smith
bacterial artificial chromosome (BAC) pSM3fr-MCK-2fl66. Infections were carried
out at 37 °C under conditions of centrifugal enhancement. In brief, after a virus
ca
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adsorption period of 30 min, cell cultures were centrifuged for 30 min at 1000 g.
Then, the virus inoculum was replaced by fresh medium. Virus titers were deter-
mined by flow cytometry of IE1 fluorescent cells at 6 h post infection or by using
the median tissue culture infective dose (TCID50) method. Unless otherwise stated,
a multiplicity of infection (MOI) of 5 IE protein forming units (IU) per cell was
used for experiments.
Bacmids. MCMV-HA-M97 and MCMV-M97-K290Q have been described
recently23. R45A/L47A, L47A/F49A, and M1STOP mutations were introduced into
MCMV-HA-M97 by traceless BAC mutagenesis67. The oligonucleotide primers
used for BAC mutagenesis are specified in Supplementary Data 5. All mutants were
controlled by diagnostic PCR and sequencing (Supplementary Fig. 5). To recon-
stitute infectious virus, BACs together with pp71 expression plasmid were trans-
fected into 3T3 fibroblasts using an Amaxa nucleofector (Lonza).
Plasmids. PCGN-based expression plasmids for HA-tagged HHV1-UL13, HHV3-
ORF47, HHV4-BGLF4, HHV5-UL97, HHV6-U69, HHV7-U69, and HHV8-
ORF36 (Addgene plasmids #26687, #26689, #26691, #26693, #26695, #26697,
#26698) were gifts from Robert Kalejta13. PCIneo-3HA-M97 was used as expres-
sion plasmid for HA-tagged M97 (ref. 23). RXL/Cy mutations were introduced by
site-directed inverse PCR-mutagenesis (primers, see Supplementary Data 5).
PHM830 (Addgene plasmid #20702) was a gift from Thomas Stamminger36.
Fragments encompassing the NLS-RXL/Cy modules of M97 and U69 were PCR-
amplified and cloned between NheI and XbaI sites of pHM830 (primers listed in
Supplementary Data 5). Plasmids were confirmed by Sanger sequencing and
purified by cesium chloride-ethidium bromide equilibrium centrifugation. PEI
MAX (Polysciences), transfection grade linear polyethylenimine hydrochloride
with a molecular weight of 40 kDa, was used for transfection.
Phosphopeptide enrichment. SILAC-labeled cells were harvested 24 h post
MCMV infection via scraping. Cells were lysed with 6M urea/2 M thiourea in
0.1 M Tris-HCl, pH 8.0. Samples were reduced with 10 mM dithiothreitol (DTT)
and alkylated with 50 mM iodoacetamide for 30 min in the dark. Proteins were
digested by lysyl endopeptidase (Wako Pure Chemicals) at an enzyme-to-protein
ratio of 1:100 (w/w) for 3 h. Subsequently, samples were diluted with 50 mM
ammonium bicarbonate to a final concentration of 2M urea. Digestion with
proteomics-grade modified trypsin (Promega) was performed at an enzyme-to-
protein ratio of 1:100 (w/w) under constant agitation for 16 h. Enzyme activity was
quenched by acidification with trifluoroacetic acid (TFA). The peptides were
desalted with C18 Stage Tips prior to nanoLC-MS/MS analysis (whole cell lysate
samples). An aliquot of the whole cell lysates were further processed for phos-
phopeptide enrichment. The tryptic digests corresponding to 200 μg protein per
condition were desalted with big C18 Stage Tips packed with 10 mg of ReproSil‐
Pur 120 C18‐AQ 5‐μm resin (Dr. Maisch GmbH). Peptides were eluted with
200 μL loading buffer, consisting of 80% acetonitrile (ACN) and 6% TFA (vol/vol).
Phosphopeptides were enriched using a microcolumn tip packed with 0.5 mg of
TiO2 (Titansphere, GL Sciences). The TiO2 tips were equilibrated with 20 μL of
loading buffer via centrifugation at 100 g. 50 μL of each sample were loaded on a
TiO2 tip via centrifugation at 100 g and this step was repeated until all the sample
was loaded. The TiO2 column was washed with 20 μL of the loading buffer, fol-
lowed by 20 μL of 50% ACN/0.1% TFA (vol/vol)). The bound phosphopeptides
were eluted using successive elution with 30 μL of 5% ammonium hydroxide and
30 μL of 5% piperidine. Each fraction was collected into a fresh tube containing
30 μL of 20% formic acid. 3 μL of 100% formic acid was added to further acidify the
samples. The phosphopeptides were desalted with C18 Stage Tips prior to nanoLC-
MS/MS analysis.
Affinity purification. At 12 and 36 h post infection (M97 interactome) or 1 day
post transfection (HHV kinases interactomes), cells were harvested by scraping in
PBS. After centrifugation at 300 g, cell pellets were lysed in 25 mM Tris-HCl (pH
7.4), 125 mM NaCl, 1 mM MgCl2, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate
(SDS), 5% glycerol, 1 mM DTT, 2 µg mL−1 aprotinin, 10 µg mL−1 leupeptin, 1 µM
pepstatin, 0.1 mM Pefabloc. For HA-AP, a µMACS HA isolation kit (Miltenyi
Biotec) was employed according to the manufacturer’s instructions, with the fol-
lowing modifications. Lysates were incubated with the magnetic beads for 1 h and
SILAC labels were mixed right before the lysates were applied to the column. Lysis
buffer was used for the first washing step, lysis buffer without detergent for the
Fig. 5 M97 causes shutoff of host DNA synthesis by Cyclin A sequestration. Serum-starved 3T3 cells were infected with the indicated recombinant
viruses and subjected to subcellular fractionation (a), cell cycle analysis (b, c), or confocal microscopy (d). a The levels of Cyclin A, E, and Cdk2 proteins
was determined at 24 h post infection in nuclear and cytosolic fractions by immunoblotting. The soluble viral nuclear protein IE1 and the cytosolic marker
GAPDH served as controls. The immunoblots are representative of three independent experiments with similar results. b, c The DNA content of infected
cells was analyzed by propidium iodide staining followed by flow cytometry and plotted as DNA histograms. b The accumulation of viral and cellular DNA
was monitored over the time course of infection. c To discriminate viral from cellular DNA replication, infected cells were treated with ganciclovir (GCV) or
left untreated. d, e At 30 hpi, infected cells were pulse-labeled with EdU. EdU staining via click-chemistry (green fluorescence) served to determine sites of
cellular and viral DNA synthesis. EdU was combined with immunofluorescence detection of the viral replication factor M57 (red fluorescence) that marks
sites of viral DNA synthesis. DAPI was used for nuclear counterstaining (blue fluorescence). Scale bars: 10 μm. e The indicated number of cells were
categorized based on the (co-)localization of EdU and M57 fluorescence within the nucleus. f Mouse embryonic fibroblasts were infected with the
indicated viruses at an MOI of 0.02. At the indicated days post infection, the infectious supernatant was harvested and subjected to virus titration. Means
(center of the error bars) and standard errors of the mean of n= 3 (3, 5, 7 days post infection) biological replicates are depicted. For 0 days post infection:










Fig. 6 The NLS-RXL module is conserved across several cell cycle regulators. a A model summarizing the function of the NLS-RXL/Cy module in infected
cells. In the absence of Cyclin A (G0/G1, early), the NLS of M97 is functional and M97 is imported into the nucleus. MCMV induces Cyclin A and drives
the cell cycle towards an S-phase environment (G1/S, late). Cyclin A binds to the RXL/Cy motif on M97 and masks the NLS, leading to cytosolic
accumulation of M97–Cyclin A complexes. Cellular DNA synthesis is inhibited due to mislocalized Cyclin A. b Conservation of RXL/Cy-NLS modules
across several cellular cell cycle regulatory proteins. The depicted sequences are of human origin.
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second and 25 mM Tris-HCl (pH 7.4) for the final washing step. Samples were
eluted in a total volume of 0.2 mL 8M guanidine hydrochloride at 95 °C. Proteins
were precipitated from the eluates by adding 1.8 mL LiChrosolv ethanol and 1 µL
GlycoBlue. After incubation at 4 °C overnight, samples were centrifuged for 1 h at
4 °C and ethanol was decanted before samples were resolved in 6M urea-2 M
thiourea buffer. Finally, samples were reduced, alkylated, digested, and desalted as
described above (phosphoproteomics).
NanoLC-MS/MS analysis. Phosphopeptides and peptides from whole cell lysates
were separated on a MonoCap C18 High Resolution 2000 column (GL Sciences) at
a flow rate of 300 nL/min. 6 and 4 h gradients were performed for whole cell
peptides and phosphopeptides, respectively. Peptides from HA-AP samples were
separated on 45 min, 2 or 4 h gradients with a 250 nL/min flow rate on a 15 cm
column (inner diameter: 75 μm), packed in-house with ReproSil-Pur C18-AQ
material (Dr. Maisch GmbH). A Q Exactive Plus instrument (Thermo Fisher) was
operated in the data-dependent mode with a full scan in the Orbitrap followed by
10 MS/MS scans, using higher-energy collision dissociation. For whole proteome
analyses, the full scans were performed with a resolution of 70,000, a target value of
3 × 106 ions, a maximum injection time of 20 ms and a 2 m/z isolation window.
The MS/MS scans were performed with a 17,500 resolution, a 1 × 106 target value
and a 60 ms maximum injection time. For phosphoproteome analysis, the full
scans were performed with a resolution of 70,000, a target value of 3 × 106 ions and
a maximum injection time of 120 ms. The MS/MS scans were performed with a
35,000 resolution, a 5 × 105 target value, 160 ms maximum injection time and a
2 m/z isolation window. For AP–MS of M97 interactomes, full scans were per-
formed at a resolution of 70,000, a target value of 1 × 106 and maximum injection
time of 120 ms. MS/MS scans were performed with a resolution of 17,500, a target
value of 1 × 105 and a maximum injection time of 60 ms. Isolation window was set
to 4.0 m/z. A Q-Exactive HF-X instrument (Thermo Fisher) or Q-Exactive Plus
instrument was used for AP–MS samples of HHV kinases. The Q-Exactive HF-X
instrument was run in Top20 data-dependent mode. Full scans were performed at
a resolution of 60,000, a target value of 3 × 106 and maximum injection time of
10ms. MS/MS scans were performed with a resolution of 15,000, a target value of
1 × 105 and a maximum injection time of 22ms. The isolation window was set to
1.3m/z. The Q-Exactive Plus instrument was run in data-dependent top10 mode.
Full scans were performed at a resolution of 70,000 a target value of 3 × 106 and
maximum injection time of 120ms. MS/MS scans were performed with a resolution
of 35,000, a target value of 5 × 105 and a maximum injection time of 120ms. The
isolation window was set to 4.0 m/z. In all cases normalized collision energy was 26.
Data analysis. Raw data were analyzed and processed using MaxQuant 1.5.2.8
(M97 interactomes) or 1.6.0.1 (phosphoproteomics, whole cell lysates, and inter-
actomes of HHV-CHPKs) software68. Search parameters included two missed
cleavage sites, fixed cysteine carbamidomethyl modification, and variable mod-
ifications including methionine oxidation, N-terminal protein acetylation,
asparagine–glutamine deamidation. In addition, serine, threonine, and tyrosine
phosphorylations were searched as variable modifications for phosphoproteome
analysis. Arg10 and Lys8 and Arg6 and Lys4 were set as labels where appropriate.
The peptide mass tolerance was 6 ppm for MS scans and 20 ppm for MS/MS scans.
The “match between runs” option was disabled and “re-quantify”, “iBAQ”
(intensity-based absolute quantification) and “second peptide” options were
enabled. Database search was performed using Andromeda, the integrated Max-
Quant search engine, against a protein database of MCMV strain Smith and a
Uniprot database of mus musculus proteins (downloaded July 2015) with common
contaminants. Raw data from AP–MS samples of HEK-293T cells were searched
against a Uniprot database of human proteins (downloaded August 2018 or
October 2016) and the sequences of transgenic HHV kinases including common
contaminants. FDR was estimated based on target-decoy competition and set to 1%
at PSM, protein and modification site level.
Bioinformatics of phosphoproteomic profiles. Phosphosite data and whole
proteome data were filtered to exclude contaminants, reverse hits and proteins only
identified by site (that is, only identified by a modified peptide). Phosphorylation
sites were ranked according to their phosphorylation localization probabilities (P)
as class I (P > 0.75), class II (0.75 > P > 0.5) and class III sites (P < 0.5). Class I sites
(in at least one of the replicates) were used with a multiplicity of one (that is, only
one phosphorylation site on a peptide). MaxQuant normalized site ratios (from
Phospho(STY)Sites.txt file) were used and corrected by the ratio of the corre-
sponding protein (from ProteinGroups.txt file) for the respective replicate. SILAC
ratios of replicates were log2 transformed, averaged and sites were considered that
were quantified in at least one of the replicates. Sites were then categorized as
belonging to nuclear or cytosolic proteins, based on the GO annotation of the
source protein. Source proteins and corresponding sites with no clear nuclear or
cytosolic annotation were classified as “no category”. To assess differences in
subcellular phosphoproteomic profiles we used the average SILAC ratio of cells
infected with R45A/L47A and L47A/F49A mutant viruses and compared phos-
phosites that belong to nuclear or cytosolic proteins (see above). One-sided Wil-
coxon rank-sum test was performed comparing these two subsets of phosphosites
with any possible amino acid in the region +4 to −4 (0 refers to the
phosphorylated amino acid). Comparisons were considered when there were at
least 19 phosphosites from both cytosolic and nuclear proteins for an amino acid at
a given position quantified.
Bioinformatics of HHV–CHPK interactomes. AP–MS data were filtered as
described above, ratios were log2 transformed and replicates were averaged (mean)
when they were quantified in all three replicates. Two-sided one sample t-tests (null
hypothesis: µ0= 0) were performed on the experimental data and a set of simulated
data where enrichment ratios were permuted for the individual replicates (999
permutations). The t-test p-values were then adjusted according to the permuted
data. The p-values in Supplementary Data 1, Fig.1 and Supplementary Fig. 1 were
adjusted in this way. Candidate interactors were selected based on a combination of
adjusted p-value and means of the three replicates. To harmonize the data obtained
from the different CHPK-IPs, we discriminated between candidate interactors and
background binders based on volcano plots. For all APs, we used a fixed p-value
cut-off of 0.05 and a flexible SILAC fold-change cut-off according to an FDR
estimation. For this, we used the simulated data as a false positive set and accepted
candidate interactors above a SILAC fold-change that recalled maximum 1% false
positives.
FDR calculations were based on the simulated data as false positives, as
previously suggested69. This yielded a set of high-confidence candidate interactors
for APs with individual HHV kinases. To compare individual prey proteins across
the APs with different kinases we imputed missing values with random values from
a normal distribution (with mean 0 and standard deviation 0.25). Enrichment
profiles were clustered using Euclidean distance and assembled into a heatmap
using R. GO enrichment of the prey proteins in selected sets of clusters were
performed using Metascape70.
Bioinformatics of M97 interactomes. AP–MS data were filtered as described
above, ratios were log2 transformed and replicates were averaged (mean) when
they were quantified in at least two of the replicates. Two-sided one sample t-tests
(null hypothesis: µ0= 0) were performed on the experimental data and proteins
were considered as interactors when they were below a t-test p-value of 0.05 and
above a log2 SILAC fold-change of 1.5. Additionally, the molar amount of bait and
prey proteins in MS samples was estimated by iBAQ values. Therefore, for samples
where M97 was purified, the iBAQ values were summed up, sorted and log10
transformed.
Immunoblot analysis. Whole cells were harvested and subsequently lysed by soni-
cation in 50mM Tris-Cl (pH 6.8), 2% SDS, 10% glycerol, 1 mM DTT, 2 µgmL−1
aprotinin, 10 µgmL−1 leupeptin, 1 µM pepstatin, 0.1mM Pefabloc. The lysates were
clarified by centrifugation and protein concentration was measured using the Bio-Rad
DC protein assay. Lysates were adjusted to equal protein concentration, supplemented
with 100mM dithiothreitol and bromophenol blue, and boiled at 95 °C for 3min. For
subcellular fractionation into nuclei and cytoplasmic extracts, cells were lysed by
Dounce homogenization in hypotonic buffer, consisting of 10mM Hepes (pH 8.0),
10mM KCl, 1.5mMMgCl2, 0.34M sucrose, 10% glycerol, 0.1mM DTT and protease
inhibitors. Nuclei were collected by low-speed centrifugation (4min, 1300 g, 4 °C).
The supernatant was clarified by high-speed centrifugation (15min, 20,000 g, 4 °C).
The nuclei were washed once in the hypotonic extraction buffer and lysed then as
described above for the preparation of whole cell lysates. Proteins were resolved by
SDS-polyacrylamide gel electrophoresis (PAGE) and blotted to polyvinylidene
fluoride membranes. To prevent nonspecific binding, blots were incubated in Tris-
buffered saline-0.1% Tween-20 (TTBS) supplemented with 5% skim milk. Afterwards
blots were incubated with the following primary antibodies: Cyclin A, C19 (Santa
Cruz); cyclin E, M20 (Santa Cruz); CDK2, M2 (Santa Cruz); HA, clone 3F10 (Roche);
M99, mouse antiserum (generously provided by Khanh Le-Trilling, University
Hospital Essen); IE1, clone Croma 101; M45, clone M45.01; M57, clone M57.02 (all
obtained from Center for Proteomics, Rijeka). The blots were developed using
horseradish peroxidase-conjugated secondary antibodies in conjunction with the
Super Signal West Dura chemiluminescence detection system (Thermo Fisher). All
antibodies were diluted to 1 µg per mL in TTBS, 5% skim milk. Uncropped scans of
the immunoblots are provided in the Source Data file.
Immunoprecipitation. Cells were lysed by freezing-thawing in IP buffer (IPB): 50
mM Tris-Cl pH 7.4, 150 mM NaCl, 10 mM MgCl2, 10 mM NaF, 0.5 mM Na3VO4,
0.5% Nonidet P-40, 10% glycerol, 1 mM DTT, 2 µg mL−1 aprotinin, 1 mM leu-
peptin, 1 mM Pefabloc. Cell extracts were clarified by centrifugation at 20,000 g.
Cyclin A IPs were performed by incubating the IPB extracts with Cyclin A, H432,
conjugated agarose beads (Santa Cruz)46. For HA IPs, a µMACS HA isolation kit
(Miltenyi Biotec) was employed according to the manufacturer’s instructions,
except that IPB was used as both lysis and washing buffer.
Kinase assay. First, HA-M97 was immunoprecipitated from infected cells. To this
end, IPB extracts were prepared and incubated with HA antibody clone 3F10 (1 µg
per mL) and Protein G-conjugated agarose beads. The precipitates were washed
several times with IPB and twice with 20 mM Tris-Cl (pH 7.4), 10 mM MgCl2, 1
mM DTT. Then, they were incubated under constant agitation for 60 min at 30 °C
in kinase reaction buffer: 20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 1 mM DTT,
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10 mM β-glycerophosphate, 50 μM ATP, 5 μCi [γ-32P]ATP. Kinase reactions were
analyzed by 8% SDS-PAGE followed by autoradiography.
Immunofluorescence microscopy. 3T3 fibroblasts were grown and infected on
glass coverslips. Where indicated, cells were incubated with 10 μM 5-ethynyl-2′-
deoxyuridine (EdU) for 30 min. To analyze for M97 localization and sites of EdU
incorporation, coverslips were washed with PBS and incubated for 10 min in PBS-
4% paraformaldehyde fixation solution, followed by additional washing and
incubation in PBS-T permeabilization solution (PBS, 0.1% Triton X-100, 0.05%
Tween 20) and 2% bovine serum albumin (BSA) fraction V/ PBS-T blocking
solution. Afterwards, incorporated EdU was conjugated to Alexa Fluor 488 using
the Click-iT EdU labeling kit (Thermo Fisher). Then samples were incubated
overnight at 4 °C with the following antibodies: anti-HA clone 3F10 or anti-M57
clone M57.02 (Center for Proteomics, Rijeka), both diluted to 1 μg mL−1 in PBS-T
containing 2% BSA. After washing in PBS, cells were incubated for 1 h at 25 °C
with Alexa Fluor 488 or 647-coupled anti-IgG antibodies (Thermo Fisher). Cov-
erslips were mounted on glass slides in 4′,6-diamidino-2-phenylindole (DAPI)
containing Fluoromount-G medium (Thermo Fisher). Images were acquired by an
Eclipse A1 laser-scanning microscope, using NIS-Elements software (Nikon
Instruments). Equal microscope settings and exposure times were used to allow
direct comparison between samples. For quantification, the microscope slides were
randomly scanned and all cells in the randomly acquired frames were analyzed by
ImageJ.
Flow cytometry. Cells were fixed and permeabilized in ice-cold PBS-80% ethanol
for at least 16 h. After washing, cells were incubated on ice for at least 16 h with one
of the following primary antibodies: anti-IE1 (clone Croma 101) or anti M57 (clone
m57.02), both diluted to 1 µg mL−1 in PBS-1% BSA. After washing, cells were
incubated in Alexa Fluor 647 conjugated anti-mouse IgG for 1 h at 25 °C. Cells
were washed again and incubated then for 15 min at 25 °C in PBS supplemented
with 0.1 mg mL−1 RNAse A and 25 μg mL−1 propidium iodide. All washing steps
and antibody dilution were performed using PBS-1% BSA. Flow cytometry was
performed using a FACSCanto II instrument equipped with FACSDiva and Cell-
Quest Pro software (Becton Dickinson).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
MS raw data and MaxQuant output tables have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identifier PXD016334.
URL. The source data underlying Figs. 1e, 2b, e, 3b–f, 4b, 5a, e, f and Supplementary Figs.
1a, b, 3c–f and 10b are provided as a Source Data file. The source data underlying
Figs. 1b–d, 3a, 4c and Supplementary Figs. 1a, c, 3b, 6b–e, 8b, c are provided in
Supplementary Data files 1–4. Fasta files for proteomic searches were downloaded from
Uniprot (https://www.uniprot.org/). All other relevant data are available from the
corresponding author upon reasonable request. Source data are provided with this paper.
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